These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2972717)
41. Kringles of substrate plasminogen provide a 'catalytic switch' in plasminogen to plasmin turnover by Streptokinase. Sharma V; Kumar S; Sahni G Biochem J; 2020 Mar; 477(5):953-970. PubMed ID: 32069359 [TBL] [Abstract][Full Text] [Related]
42. Structure of the complex of the antistasin-type inhibitor bdellastasin with trypsin and modelling of the bdellastasin-microplasmin system. Rester U; Bode W; Moser M; Parry MA; Huber R; Auerswald E J Mol Biol; 1999 Oct; 293(1):93-106. PubMed ID: 10512718 [TBL] [Abstract][Full Text] [Related]
43. The activation-resistant conformation of recombinant human plasminogen is stabilized by basic residues in the amino-terminal hinge region. Horrevoets AJ; Smilde AE; Fredenburgh JC; Pannekoek H; Nesheim ME J Biol Chem; 1995 Jun; 270(26):15770-6. PubMed ID: 7797579 [TBL] [Abstract][Full Text] [Related]
44. Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin. Clemmensen I; Petersen LC; Kluft C Eur J Biochem; 1986 Apr; 156(2):327-33. PubMed ID: 3009181 [TBL] [Abstract][Full Text] [Related]
45. Mechanism of the urokinase-catalyzed activation of human plasminogen. Violand BN; Castellino FJ J Biol Chem; 1976 Jul; 251(13):3906-12. PubMed ID: 132442 [TBL] [Abstract][Full Text] [Related]
46. Purification and characterization of A61. An angiostatin-like plasminogen fragment produced by plasmin autodigestion in the absence of sulfhydryl donors. Kassam G; Kwon M; Yoon CS; Graham KS; Young MK; Gluck S; Waisman DM J Biol Chem; 2001 Mar; 276(12):8924-33. PubMed ID: 11114303 [TBL] [Abstract][Full Text] [Related]
47. A proenzyme from chicken plasma similar to human plasma prekallikrein. Schleuning WD; Sudol M; Reich E J Biol Chem; 1983 Dec; 258(23):14106-15. PubMed ID: 6557113 [TBL] [Abstract][Full Text] [Related]
48. Characterization of a recombinant fusion protein of the finger domain of tissue-type plasminogen activator with a truncated single chain urokinase-type plasminogen activator. Gheysen D; Lijnen HR; Piérard L; de Foresta F; Demarsin E; Jacobs P; De Wilde M; Bollen A; Collen D J Biol Chem; 1987 Aug; 262(24):11779-84. PubMed ID: 3114253 [TBL] [Abstract][Full Text] [Related]
49. [Features of the interaction of Glu- and Lys-forms of plasminogen with native and partially hydrolyzed fibrin]. Grinenko TV; Skomorovskaia EV; Kudinov SA; Zolotareva EN Biokhimiia; 1992 May; 57(5):728-37. PubMed ID: 1322196 [TBL] [Abstract][Full Text] [Related]
50. Production of the modified form of human plasminogen by alpha 2-macroglobulin-plasmin complexes. Yamamoto J; Okamoto U; Morita S; Asada N; Yamaoka M Jpn J Physiol; 1985; 35(6):1013-21. PubMed ID: 2422420 [TBL] [Abstract][Full Text] [Related]
51. Stabilization of plasmin by lysine derivatives. Ueshima S; Okada K; Matsuo O Clin Chim Acta; 1996 Feb; 245(1):7-18. PubMed ID: 8646816 [TBL] [Abstract][Full Text] [Related]
52. Functional Kunitz inhibitor binding domain in plasmin-derived light chain as shown by affinity chromatography. Chauvet J; Chabbat J; Acher R Int J Pept Protein Res; 1986 Jul; 28(1):85-90. PubMed ID: 2944852 [TBL] [Abstract][Full Text] [Related]
53. Monoclonal antibodies inhibitory to human plasmin. Definitive demonstration of a role for plasmin in activating the proenzyme of urokinase-type plasminogen activator. Sim PS; Fayle DR; Doe WF; Stephens RW Eur J Biochem; 1986 Aug; 158(3):537-42. PubMed ID: 2942403 [TBL] [Abstract][Full Text] [Related]
54. Requirement of zymogen modification for activation of porcine plasminogen. Machovich R; Litwiller RD; Owen WG Biochemistry; 1992 Nov; 31(46):11558-61. PubMed ID: 1445889 [TBL] [Abstract][Full Text] [Related]
55. Kinetic studies on the plasminogen activation by the staphylokinase-plasmin complex. Shibata H; Nagaoka M; Sakai M; Sawada H; Watanabe T; Yokokura T J Biochem; 1994 Apr; 115(4):738-42. PubMed ID: 8089091 [TBL] [Abstract][Full Text] [Related]
56. Activation of plasminogen as a feature in its assay. Gaffney PJ; Brasher M; Lord K; Kirkwood TB Haemostasis; 1977; 6(1):72-88. PubMed ID: 140114 [TBL] [Abstract][Full Text] [Related]
57. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins. Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568 [TBL] [Abstract][Full Text] [Related]
58. Isolation and characterization of a urokinase-type plasminogen activator (Mr = 54,000) from cultured human endothelial cells indistinguishable from urinary urokinase. Booyse FM; Osikowicz G; Feder S; Scheinbuks J J Biol Chem; 1984 Jun; 259(11):7198-205. PubMed ID: 6539333 [TBL] [Abstract][Full Text] [Related]
59. The importance of the preactivation peptide in the two-stage mechanism of human plasminogen activation. Walther PJ; Hill RL; McKee PA J Biol Chem; 1975 Aug; 250(15):5926-33. PubMed ID: 1150667 [TBL] [Abstract][Full Text] [Related]
60. Structural relationship between "glutamic acid" and "lysine" forms of human plasminogen and their interaction with the NH2-terminal activation peptide as studied by affinity chromatography. Wiman B; Wallén P Eur J Biochem; 1975 Jan; 50(3):489-94. PubMed ID: 122932 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]